1. Home
  2. PDYN vs CTNM Comparison

PDYN vs CTNM Comparison

Compare PDYN & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDYN
  • CTNM
  • Stock Information
  • Founded
  • PDYN 1983
  • CTNM 2009
  • Country
  • PDYN United States
  • CTNM United States
  • Employees
  • PDYN N/A
  • CTNM N/A
  • Industry
  • PDYN Wholesale Distributors
  • CTNM
  • Sector
  • PDYN Industrials
  • CTNM
  • Exchange
  • PDYN Nasdaq
  • CTNM Nasdaq
  • Market Cap
  • PDYN 271.4M
  • CTNM 248.7M
  • IPO Year
  • PDYN N/A
  • CTNM 2024
  • Fundamental
  • Price
  • PDYN $8.81
  • CTNM $11.70
  • Analyst Decision
  • PDYN Hold
  • CTNM Strong Buy
  • Analyst Count
  • PDYN 1
  • CTNM 5
  • Target Price
  • PDYN $8.00
  • CTNM $22.20
  • AVG Volume (30 Days)
  • PDYN 2.7M
  • CTNM 113.0K
  • Earning Date
  • PDYN 11-12-2025
  • CTNM 11-05-2025
  • Dividend Yield
  • PDYN N/A
  • CTNM N/A
  • EPS Growth
  • PDYN N/A
  • CTNM N/A
  • EPS
  • PDYN N/A
  • CTNM N/A
  • Revenue
  • PDYN $4,357,000.00
  • CTNM N/A
  • Revenue This Year
  • PDYN N/A
  • CTNM N/A
  • Revenue Next Year
  • PDYN $97.52
  • CTNM N/A
  • P/E Ratio
  • PDYN N/A
  • CTNM N/A
  • Revenue Growth
  • PDYN N/A
  • CTNM N/A
  • 52 Week Low
  • PDYN $1.69
  • CTNM $3.35
  • 52 Week High
  • PDYN $14.95
  • CTNM $20.24
  • Technical
  • Relative Strength Index (RSI)
  • PDYN 48.75
  • CTNM 53.50
  • Support Level
  • PDYN $8.27
  • CTNM $11.56
  • Resistance Level
  • PDYN $10.73
  • CTNM $12.87
  • Average True Range (ATR)
  • PDYN 1.01
  • CTNM 0.84
  • MACD
  • PDYN -0.08
  • CTNM -0.07
  • Stochastic Oscillator
  • PDYN 22.29
  • CTNM 44.59

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: